Improvement of myocardial fibrosis injury by Shengmai injection in ischemia-induced heart failure in a rat model
Abstract. Background. Heart failure (HF) is the leading cause of death worldwide. Myocardial infarction (MI) is a major contributor to HF. Shengmai injection (SMI) has exhibited protective efficacy in preventing HF. However, the advantages of SMI in the progression of MI-induced HF remain unclear. O...
Saved in:
| Main Authors: | Yurong Ding, Junying Wei, Enhui Ji, Menglan Wang, Yue Wu, Mengli Chang, Yi Zhang, Jing Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2024-09-01
|
| Series: | Science of Traditional Chinese Medicine |
| Online Access: | http://journals.lww.com/10.1097/st9.0000000000000040 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of Dengzhan Shengmai capsule in the treatment of chronic heart failure: a systematic review and meta-analysis
by: Shenghua Lu, et al.
Published: (2025-02-01) -
Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
by: Cong Wu, et al.
Published: (2025-06-01) -
Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome
by: Lingmei Li, et al.
Published: (2025-01-01) -
Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
by: T. B. Pecherina, et al.
Published: (2020-11-01) -
Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts
by: Xinhua Yao, et al.
Published: (2015-01-01)